RobertAlanRosenheckMD
Psychiatry • West Haven, CTProfessor of Psychiatry, Public Health and at the Child Study Center at Yale Medical School Director of the Division of Mental Health Services and Outcomes Research in the Department of Psychiatry.
Dr. Rosenheck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
950 Campbell Ave.
West Haven, CT 06516Phone+1 203-937-3850Fax+1 203-937-3433
Education & Training
Yale-New Haven Medical CenterResidency, Psychiatry, 1973 - 1976
Perelman School of Medicine at the University of PennsylvaniaClass of 1973
Certifications & Licensure
CT State Medical License 1974 - 2025- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia Start of enrollment: 1998 Mar 01
- Long-Acting Injectable Risperidone in the Treatment of Schizophrenia Start of enrollment: 2006 Sep 01
- Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia Start of enrollment: 2010 Oct 01
Publications & Presentations
PubMed
- 38 citationsHomelessness among a nationally representative sample of US veterans: prevalence, service utilization, and correlatesJack Tsai, Bruce G. Link, Robert A. Rosenheck, Robert H. Pietrzak
Social Psychiatry and Psychiatric Epidemiology. 2016-04-13 - 139 citationsAge effects on antidepressant-induced manic conversion.Andrés Martin, Christopher Young, James F. Leckman, Chengeto Mukonoweshuro, Robert A. Rosenheck
Archives of Pediatrics & Adolescent Medicine. 2004-08-01 - 105 citationsAssociation of substance use and VA service-connected disability benefits with risk of homelessness among veteransEllen L. Edens, Wes Kasprow, Jack Tsai, Robert A. Rosenheck
The American Journal on Addictions. 2011-09-01
Journal Articles
- Impact of Comprehensive Treatment for First Episode Psychosis on Substance Use Outcomes: A Randomized Controlled TrialCorinne Cather, Robert Rosenheck, Christoph U Correll, Psychiatry Research
Authored Content
- Impact of Comprehensive Treatment for First Episode Psychosis on Substance Use Outcomes: A Randomized Controlled TrialAugust 2018
Press Mentions
Medical Cannabis Use Rising in US, Highlighting Need for Clinical GuidelinesMarch 24th, 2023- Medical Marijuana Use Has Doubled in the U.S., Study from Department of Veterans Affairs Officials FindsMarch 16th, 2023
- Military Service Has Transgenerational Impact Study ShowsAugust 30th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
